Get started

Financials · EOLS

Evolus Inc. (EOLS) financials

For the twelve months ended Sep 30, 2026, Evolus Inc. reported $325.47M of revenue and -$31.11M of net income.

Revenue, TTM
$325.47M
Revenue growth, YoY
+13.9%
Net income, TTM
-$31.11M
Net margin
-9.6%
Free cash flow, TTM
-$4.91M
EPS, diluted, TTM
-$0.46
Cash
$41.70M
Total debt
$156.90M
P/S
1.38
Market cap
$450.4M
Annual revenue$297.18M
FY2018FY2025
Annual net income-$51.64M
FY2017FY2025
Annual free cash flow-$45.71M
FY2017FY2025

EOLS revenue and earnings growth

EOLS revenueQ3 2026$77.95M

Quarter YoY
+13.0%
QoQ
-7.3%
FY YoY
+11.6%
5Y CAGR
+39.4%

EOLS revenue was $77.95M in fiscal Q3 2026 (ended Sep 30, 2026), up 13.0% from a year earlier and down 7.3% from the prior quarter. For the full fiscal 2025 it was $297.18M, up 11.6% from fiscal 2024. Compound annual growth was +39.4% over 5 years. It rose in each of the last 6 fiscal years. Fiscal 2025 is the highest of the 8 fiscal years on file.

EOLS net incomeQ3 2026-$12.52M

EOLS net income was -$12.52M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$15.74M a year earlier. For the full fiscal 2025 it was -$51.64M, compared with -$50.42M in fiscal 2024.

EOLS EPSQ3 2026-$0.19

EOLS diluted EPS was -$0.19 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.24 a year earlier. For the full fiscal 2025 it was -$0.80, compared with -$0.81 in fiscal 2024.

EOLS free cash flowQ3 2026-$2.25M

EOLS free cash flow was -$2.25M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$15.62M a year earlier. For the full fiscal 2025 it was -$45.71M, compared with -$19.47M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Revenue$297.18M$266.27M$202.09M$148.62M$99.67M$56.54M$34.92M$0-
Cost of revenue$100.07M$83.97M$64.51M$58.84M$43.53M$18.30M$8.01M$0-
Gross profit$197.11M$182.30M$137.57M$89.77M$56.14M$38.24M$26.91M$0-
Research and development$9.58M$9.17M$6.56M$4.74M$2.06M$1.72M$3.97M$6.49M$6.69M
Selling, general and admin$220.79M$198.03M$164.94M$141.84M$112.07M$98.19M$113.59M$29.15M$4.82M
Operating income-$32.66M-$34.41M-$49.23M-$65.33M-$44.41M-$153.07M-$98.95M-$46.14M-$11.73M
Interest expense$19.69M$18.73M$13.83M$9.10M$1.40M--$863.0K$5.0K
Pre-tax income-$50.96M-$49.76M-$61.51M-$74.32M-$46.77M-$162.94M-$105.06M-$46.80M-$11.73M
Income tax$677.0K$664.0K$176.0K$95.0K$42.0K$77.0K-$15.03M$65.0K-$7.25M
Net income-$51.64M-$50.42M-$61.69M-$74.41M-$46.81M-$163.01M-$90.03M-$46.87M-$4.48M
EPS, basic-$0.80-$0.81-$1.08-$1.33-$0.94-$4.83-$3.19-$1.92-$0.27
EPS, diluted-$0.80-$0.81-$1.08-$1.33-$0.94-$4.83-$3.19-$1.92-$0.27
Diluted shares64.5M62.0M56.9M56.1M49.8M33.7M28.2M24.4M16.5M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Cash and equivalents$53.83M$86.95M$62.84M$53.92M$146.26M$102.56M$109.89M$93.16M$0
Receivables$54.70M$47.68M$30.53M$22.45M$14.66M$9.68M$10.66M$0-
Inventory$26.96M$12.16M$11.00M$18.85M$1.76M$3.35M$6.41M$0-
Current assets$142.92M$151.34M$112.42M$100.80M$178.80M$127.61M$152.20M$94.34M$72.82M
Goodwill$21.21M$21.21M$21.21M$21.21M$21.21M$21.21M$21.21M$21.21M$21.21M
Total assets$225.87M$232.57M$189.00M$177.98M$257.48M$209.07M$240.44M$171.84M$152.23M
Current liabilities$75.31M$62.96M$48.29M$46.51M$57.66M$180.25M$24.44M$5.28M$212.75M
Long-term debt$146.10M$121.51M--$0$40.51M$0$0-
Total debt$146.10M$121.51M$120.36M$71.88M$0$40.51M$0$0-
Total liabilities$248.97M$227.05M$209.69M$159.48M$175.61M$282.03M$160.99M$87.46M$227.78M
Shareholders' equity-$23.11M$5.52M-$20.69M$18.50M$81.88M-$72.96M$79.46M$84.38M-$75.54M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Operating cash flow-$42.27M-$18.00M-$34.01M-$84.91M-$33.39M-$57.87M-$93.38M-$25.67M-$13.22M
Capital expenditures$3.44M$1.47M$473.0K$1.62M$393.0K$815.0K$345.0K$9.0K$0
Free cash flow-$45.71M-$19.47M-$34.48M-$86.53M-$33.78M-$58.69M-$93.73M-$25.68M-$13.22M
Investing cash flow-$8.45M-$4.82M-$1.63M-$2.94M$4.03M$12.19M-$23.43M-$9.0K$0
Financing cash flow$17.34M$47.41M$44.64M-$4.15M$73.05M$38.35M$133.55M$118.84M$13.04M
Stock-based compensation$20.70M$22.25M$16.46M$10.83M$9.58M$10.58M$9.52M$6.97M$586.0K
Depreciation and amortization$7.51M$5.30M$5.13M$3.72M$5.62M$7.03M$4.13M$9.0K$218.0K

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
Revenue growth, YoY11.6%31.8%36.0%49.1%76.3%61.9%---
Gross margin66.3%68.5%68.1%60.4%56.3%67.6%77.1%--
Operating margin-11.0%-12.9%-24.4%-44.0%-44.6%-270.7%-283.3%--
Net margin-17.4%-18.9%-30.5%-50.1%-47.0%-288.3%-257.8%--
Free cash flow margin-15.4%-7.3%-17.1%-58.2%-33.9%-103.8%-268.4%--
Return on equity--913.1%--402.2%-57.2%--113.3%-55.5%-
Return on assets-22.9%-21.7%-32.6%-41.8%-18.2%-78.0%-37.4%-27.3%-2.9%
Current ratio1.902.402.332.173.100.716.2317.880.34
Debt to equity-22.00-3.890.00-0.000.00-

Source: XBRL data Evolus Inc. files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

EOLS peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
EOLS$325.47M+13.9%-$31.11M-9.6%$450.4M
LLY$86.46B+45.5%$27.58B31.9%$1.27T
JNJ$99.33B+7.8%$16.09B16.2%$664.95B
ABBV$66.01B+10.7%$10.34B15.7%$514.92B
MRK$67.38B+4.9%$2.45B3.6%$361.71B
NVS$54.53B+8.4%$13.98B25.6%$310.17B
AZN$58.74B+8.6%$10.22B17.4%$289.10B
ABT$48.23B+10.0%$4.70B9.7%$190.39B
NVODKK 309.06B+6.4%DKK 102.43B33.1%$178.51B

EOLS FAQ

9 questions
  • What is EOLS revenue?
    Evolus Inc. (EOLS) reported $325.47M of revenue for the twelve months ended Sep 30, 2026. That is up 13.9% from the year before. Revenue for fiscal 2025 was $297.18M.
  • Is EOLS profitable?
    No. Evolus Inc. reported a net loss of $31.11M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does EOLS have?
    Evolus Inc. reported $41.70M in cash and cash equivalents and $156.90M of debt on its most recent balance sheet in SEC filings.
  • How fast is EOLS revenue growing?
    Evolus Inc.'s revenue changed +11.6% in fiscal 2025, to $297.18M. Its compound annual growth rate was +39.4% over 5 years.
  • What is EOLS gross margin?
    Evolus Inc.'s gross profit was $216.05M on $325.47M of revenue for the twelve months ended Sep 30, 2026, a gross margin of 66.4%.
  • What is EOLS free cash flow?
    Evolus Inc. generated -$4.91M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of -$2.65M less capital expenditures.
  • What is EOLS earnings per share?
    Diluted earnings per share were -$0.46 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did EOLS last report financial results?
    The latest statements here come from Evolus Inc.'s 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
  • Where does this EOLS financial data come from?
    Quantisnow builds these statements from the structured XBRL data Evolus Inc. files with the SEC. It is provided for information only and is not investment advice.